Stegostoma fasciatum isolate 6-17 chromosome 17, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039243.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
STIM activating enhance, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
STIM activating enhance, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
store-operated calcium entry regulator STIMATE isoform X1
store-operated calcium entry regulator STIMATE isoform X2
musculoskeletal embryonic nuclear protein 1-like
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
protein kinase C delta type-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
protein kinase C delta type-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein kinase C delta type-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 48 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4-like isoform X2
neural Wiskott-Aldrich syndrome protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytochrome b-c1 complex subunit 1, mitochondrial-like
NADH:ubiquinone oxidoreductase complex assembly factor
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3
IMP (inosine 5'-monophosphate) dehydrogenase 2, transcript variant X2
IMP (inosine 5'-monophosphate) dehydrogenase 2, transcript variant X1
inosine-5'-monophosphate dehydrogenase 2 isoform X2
inosine-5'-monophosphate dehydrogenase 2 isoform X1
transcriptional regulator QRICH1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
transcriptional regulator QRICH1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
transcriptional regulator QRICH1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
transcriptional regulator QRICH1-like isoform X2
transcriptional regulator QRICH1-like isoform X1
transcriptional regulator QRICH1-like isoform X3
serine/threonine-protein kinase pim-3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
G-protein coupled receptor 22-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G-protein coupled receptor 22-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
G-protein coupled receptor 22-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
G-protein coupled receptor 22-like, transcript variant X4
sodium- and chloride-dependent creatine transporter 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin carboxyl-terminal hydrolase 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
cytosolic 10-formyltetrahydrofolate dehydrogenase-like
Kruppel-like factor 15, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Kruppel-like factor 15, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kruppel-like factor 15, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Kruppel-like factor 15, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Kruppel-like factor 15, transcript variant X10
Kruppel-like factor 15, transcript variant X3
Kruppel-like factor 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Kruppel-like factor 15, transcript variant X5
Kruppel-like factor 15, transcript variant X7
Kruppel-like factor 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Kruppel-like factor 15, transcript variant X8
Kruppel-like factor 15, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cilia and flagella associated protein 100
cilia- and flagella-associated protein 100
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial intermembrane space import and assembly protein 40-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
transmembrane protein 43-like, transcript variant X1
transmembrane protein 43-like, transcript variant X2
transmembrane protein 43-like isoform X1
transmembrane protein 43-like isoform X2
xeroderma pigmentosum, complementation group C
DNA repair protein complementing XP-C cells
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125460506, transcript variant X2
uncharacterized LOC125460506, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium- and chloride-dependent taurine transporter-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 123 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
sodium- and chloride-dependent taurine transporter-like, transcript variant X3
sodium- and chloride-dependent taurine transporter-like, transcript variant X2
sodium- and chloride-dependent taurine transporter-like
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform-like
coiled-coil domain-containing protein 71-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 126 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
host cell factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
host cell factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
GATA-binding factor 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
GATA-binding factor 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
GATA-binding factor 2-like, transcript variant X6
GATA-binding factor 2-like, transcript variant X4
GATA-binding factor 2-like, transcript variant X2
GATA-binding factor 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 41 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GATA-binding factor 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
eukaryotic elongation factor, selenocysteine-tRNA-specific
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
selenocysteine-specific elongation factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
protein transport protein Sec61 subunit alpha-like 1
kelch repeat and BTB (POZ) domain containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
kelch repeat and BTB (POZ) domain containing 12, transcript variant X1
kelch repeat and BTB domain-containing protein 12 isoform X2
kelch repeat and BTB domain-containing protein 12 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
monoglyceride lipase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
monoglyceride lipase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and BTB (POZ) domain containing 1, transcript variant X2
ankyrin repeat and BTB (POZ) domain containing 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ankyrin repeat and BTB (POZ) domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
ankyrin repeat and BTB/POZ domain-containing protein 1
podocalyxin-like 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
podocalyxin-like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
podocalyxin-like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
podocalyxin-like 2, transcript variant X3
minichromosome maintenance complex component 2, transcript variant X2
minichromosome maintenance complex component 2, transcript variant X1
DNA replication licensing factor MCM2 isoform X1
DNA replication licensing factor MCM2 isoform X2
transmembrane protein, adipocyte asscociated 1, transcript variant X2
transmembrane protein, adipocyte asscociated 1, transcript variant X1
transmembrane protein, adipocyte asscociated 1, transcript variant X3
transmembrane protein adipocyte-associated 1 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
5-hydroxymethylcytosine binding, ES cell specific, transcript variant X1
5-hydroxymethylcytosine binding, ES cell specific, transcript variant X2
coatomer subunit gamma-1, transcript variant X2
coatomer subunit gamma-1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC125460465, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC125460465, transcript variant X2
DALR anticodon binding domain containing 3, transcript variant X3
DALR anticodon binding domain containing 3, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
DALR anticodon binding domain containing 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
DALR anticodon binding domain containing 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
DALR anticodon binding domain containing 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
DALR anticodon-binding domain-containing protein 3 isoform X1
DALR anticodon-binding domain-containing protein 3 isoform X2
DALR anticodon binding domain containing 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
DALR anticodon binding domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DALR anticodon-binding domain-containing protein 3 isoform X3
DALR anticodon-binding domain-containing protein 3 isoform X5
DALR anticodon binding domain containing 3, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
DALR anticodon binding domain containing 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
DALR anticodon binding domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DALR anticodon-binding domain-containing protein 3 isoform X4
DALR anticodon binding domain containing 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
DALR anticodon-binding domain-containing protein 3 isoform X6
DALR anticodon-binding domain-containing protein 3 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein kinase, cAMP-dependent, regulatory, type II, alpha A, transcript variant X2
protein kinase, cAMP-dependent, regulatory, type II, alpha A isoform X2
protein kinase, cAMP-dependent, regulatory, type II, alpha A, transcript variant X1
protein kinase, cAMP-dependent, regulatory, type II, alpha A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cytokine-inducible SH2-containing protein-like, transcript variant X2
cytokine-inducible SH2-containing protein-like, transcript variant X1
cytokine-inducible SH2-containing protein-like isoform X1
cytokine-inducible SH2-containing protein-like isoform X2
HemK methyltransferase family member 1, transcript variant X3
HemK methyltransferase family member 1, transcript variant X1
HemK methyltransferase family member 1, transcript variant X2
MTRF1L release factor glutamine methyltransferase isoform X2
MTRF1L release factor glutamine methyltransferase isoform X1
uncharacterized protein C3orf18, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein C3orf18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein C3orf18, transcript variant X4
uncharacterized protein C3orf18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein C3orf18, transcript variant X3
high mobility group protein HMGI-C-like, transcript variant X2
high mobility group protein HMGI-C-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00548
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl, transcript variant X5
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl isoform X4
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl isoform X1
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl isoform X2
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl isoform X3
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3bl isoform X5
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X6
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X1
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X7
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X5
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X9
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X4
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X8
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X2
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
ETS domain-containing protein Elk-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
ETS domain-containing protein Elk-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ETS domain-containing protein Elk-1-like
BRICK1 subunit of SCAR/WAVE actin nucleating complex
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
FA complementation group D2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
FA complementation group D2, transcript variant X2
FA complementation group D2, transcript variant X3
Fanconi anemia group D2 protein isoform X1
Fanconi anemia group D2 protein isoform X2
ubiquitin specific peptidase 4 (proto-oncogene)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 110 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 108 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transforming protein RhoA, transcript variant X1
transforming protein RhoA, transcript variant X2
T-cell leukemia translocation-altered gene protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
inka box actin regulator 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
inka box actin regulator 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ubiquitin-like modifier-activating enzyme 1
TRAF-interacting protein, transcript variant X3
TRAF-interacting protein, transcript variant X1
TRAF-interacting protein, transcript variant X2
E3 ubiquitin-protein ligase TRAIP isoform X2
E3 ubiquitin-protein ligase TRAIP isoform X1
caM kinase-like vesicle-associated protein, transcript variant X1
caM kinase-like vesicle-associated protein, transcript variant X4
caM kinase-like vesicle-associated protein, transcript variant X3
caM kinase-like vesicle-associated protein, transcript variant X2
caM kinase-like vesicle-associated protein isoform X2
caM kinase-like vesicle-associated protein isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
macrophage-stimulating protein receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
macrophage-stimulating protein receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
macrophage-stimulating protein receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
macrophage-stimulating protein receptor-like
MON1 secretory trafficking family member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RNA-binding protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RNA-binding protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
RNA-binding protein 5-like, transcript variant X4
RNA-binding protein 5-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
RNA-binding protein 5-like, transcript variant X6
RNA-binding protein 5-like, transcript variant X7
RNA-binding protein 5-like, transcript variant X5
RNA-binding protein 5-like, transcript variant X3
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X3
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X1
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X2
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X5
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X6
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X4
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3Fb, transcript variant X7
guanine nucleotide-binding protein G(t) subunit alpha-like
guanine nucleotide-binding protein G(i) subunit alpha-2, transcript variant X1
guanine nucleotide-binding protein G(i) subunit alpha-2, transcript variant X2
guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X1
guanine nucleotide-binding protein G(i) subunit alpha-2 isoform X2
spindle apparatus coiled-coil protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
spindle apparatus coiled-coil protein 1, transcript variant X3
spindle apparatus coiled-coil protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium-coupled neutral amino acid transporter 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon-related developmental regulator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon-related developmental regulator 2, transcript variant X2
interferon-related developmental regulator 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
interferon-related developmental regulator 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
interferon-related developmental regulator 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
interferon-related developmental regulator 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
interferon-related developmental regulator 2 isoform X1
interferon-related developmental regulator 2 isoform X2
interferon-related developmental regulator 2 isoform X5
interferon-related developmental regulator 2 isoform X3
interferon-related developmental regulator 2 isoform X4
interferon-related developmental regulator 2 isoform X6
hyaluronidase-1-like, transcript variant X1
hyaluronidase-1-like, transcript variant X2
hyaluronidase-1-like, transcript variant X4
hyaluronidase-1-like, transcript variant X3
hyaluronidase-1-like, transcript variant X5
hyaluronidase-1-like, transcript variant X6
hyaluronidase-1-like, transcript variant X8
hyaluronidase-1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
cadherin, EGF LAG seven-pass G-type receptor 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
cadherin EGF LAG seven-pass G-type receptor 3
deoxyribonuclease 1 like 4, tandem duplicate 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
deoxyribonuclease 1 like 4, tandem duplicate 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
deoxyribonuclease 1 like 4, tandem duplicate 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
deoxyribonuclease 1 like 4, tandem duplicate 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
deoxyribonuclease 1 like 4, tandem duplicate 1, transcript variant X2
deoxyribonuclease 1 like 4, tandem duplicate 1 isoform X1
deoxyribonuclease 1 like 4, tandem duplicate 1 isoform X2
deoxyribonuclease 1 like 4, tandem duplicate 1 isoform X3
deoxyribonuclease 1 like 4, tandem duplicate 1 isoform X4
translation machinery associated 7 homolog
translation machinery-associated protein 7
myotubularin related protein 14, transcript variant X3
myotubularin related protein 14, transcript variant X5
myotubularin related protein 14, transcript variant X2
myotubularin related protein 14, transcript variant X4
myotubularin related protein 14, transcript variant X1
myotubularin-related protein 14 isoform X3
myotubularin-related protein 14 isoform X5
myotubularin-related protein 14 isoform X2
myotubularin-related protein 14 isoform X4
myotubularin-related protein 14 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LHFPL tetraspan subfamily member 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LHFPL tetraspan subfamily member 4a, transcript variant X3
LHFPL tetraspan subfamily member 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
LHFPL tetraspan subfamily member 4a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LHFPL tetraspan subfamily member 4a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LHFPL tetraspan subfamily member 3 protein isoform X2
LHFPL tetraspan subfamily member 4 protein isoform X4
LHFPL tetraspan subfamily member 4 protein isoform X3
LHFPL tetraspan subfamily member 3 protein isoform X1
SET domain containing 5, transcript variant X7
SET domain containing 5, transcript variant X9
SET domain containing 5, transcript variant X2
SET domain containing 5, transcript variant X6
SET domain containing 5, transcript variant X8
SET domain containing 5, transcript variant X5
SET domain containing 5, transcript variant X3
SET domain containing 5, transcript variant X4
SET domain containing 5, transcript variant X11
SET domain containing 5, transcript variant X10
SET domain containing 5, transcript variant X1
histone-lysine N-methyltransferase SETD5 isoform X3
histone-lysine N-methyltransferase SETD5 isoform X2
histone-lysine N-methyltransferase SETD5 isoform X1
UBA_like_SF and PTH2 domain-containing protein, transcript variant X2
UBA_like_SF and PTH2 domain-containing protein, transcript variant X3
UBA_like_SF and PTH2 domain-containing protein, transcript variant X1
UBA_like_SF and PTH2 domain-containing protein
SRSF protein kinase 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SRSF protein kinase 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SRSF protein kinase 3-like, transcript variant X2
ankyrin repeat and SOCS box protein 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
coiled-coil domain containing 51, transcript variant X4
coiled-coil domain containing 51, transcript variant X3
coiled-coil domain containing 51, transcript variant X2
coiled-coil domain containing 51, transcript variant X1
coiled-coil domain containing 51, transcript variant X5
coiled-coil domain containing 51, transcript variant X6
mitochondrial potassium channel isoform X1
mitochondrial potassium channel isoform X2
bromodomain and PHD finger containing, 1, transcript variant X1
bromodomain and PHD finger containing, 1, transcript variant X2
8-oxoguanine DNA glycosylase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
8-oxoguanine DNA glycosylase, transcript variant X1
8-oxoguanine DNA glycosylase, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
8-oxoguanine DNA glycosylase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
8-oxoguanine DNA glycosylase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
8-oxoguanine DNA glycosylase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
elongation factor 1-alpha, somatic form-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 308 Proteins, and 10% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125460438, transcript variant X8
uncharacterized LOC125460438, transcript variant X3
uncharacterized LOC125460438, transcript variant X2
uncharacterized LOC125460438, transcript variant X4
uncharacterized LOC125460438, transcript variant X6
uncharacterized LOC125460438, transcript variant X7
uncharacterized LOC125460438, transcript variant X9
uncharacterized LOC125460438, transcript variant X1
uncharacterized LOC125460438, transcript variant X5
uncharacterized protein LOC125460438 isoform X1
uncharacterized protein LOC125460438 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
interleukin-17 receptor C-like, transcript variant X4
interleukin-17 receptor C-like, transcript variant X3
interleukin-17 receptor C-like, transcript variant X1
interleukin-17 receptor C-like, transcript variant X2
interleukin-17 receptor C-like isoform X2
interleukin-17 receptor C-like isoform X1
interleukin-17 receptor C-like isoform X3
cell death inducing DFFA like effector c, transcript variant X3
cell death inducing DFFA like effector c, transcript variant X2
cell death inducing DFFA like effector c, transcript variant X1
mitochondrial mRNA pseudouridine synthase RPUSD3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
mitochondrial mRNA pseudouridine synthase RPUSD3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
mitochondrial mRNA pseudouridine synthase RPUSD3-like, transcript variant X1
mitochondrial mRNA pseudouridine synthase RPUSD3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
mitochondrial mRNA pseudouridine synthase RPUSD3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
mitochondrial mRNA pseudouridine synthase RPUSD3-like isoform X1
mitochondrial mRNA pseudouridine synthase RPUSD3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
transcriptional adaptor 3 (NGG1 homolog, yeast)-like, transcript variant X1
transcriptional adaptor 3 (NGG1 homolog, yeast)-like, transcript variant X2
transcriptional adaptor 3 (NGG1 homolog, yeast)-like, transcript variant X4
transcriptional adaptor 3 (NGG1 homolog, yeast)-like, transcript variant X3
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
calcium/calmodulin-dependent protein kinase Ib, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium/calmodulin-dependent protein kinase type 1 isoform X1
calcium/calmodulin-dependent protein kinase Ib, transcript variant X3
calcium/calmodulin-dependent protein kinase Ib, transcript variant X2
calcium/calmodulin-dependent protein kinase type 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized protein C3orf84-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC125460237 isoform X3
uncharacterized protein C3orf84-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized protein C3orf84-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein C3orf84-like, transcript variant X5
uncharacterized protein C3orf84-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein C3orf84-like isoform X4
uncharacterized protein LOC125460237 isoform X2
uncharacterized protein C3orf84-like isoform X5
uncharacterized protein LOC125460237 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized si:dkey-32e6.3, transcript variant X2
uncharacterized si:dkey-32e6.3, transcript variant X1
inter-alpha-trypsin inhibitor heavy chain H3-like, transcript variant X1
inter-alpha-trypsin inhibitor heavy chain H3-like, transcript variant X2
inter-alpha-trypsin inhibitor heavy chain H3-like isoform X1
inter-alpha-trypsin inhibitor heavy chain H3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
inter-alpha-trypsin inhibitor heavy chain H3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
inter-alpha-trypsin inhibitor heavy chain H3-like isoform X3
inter-alpha-trypsin inhibitor heavy chain H3-like, transcript variant X4
inter-alpha-trypsin inhibitor heavy chain H3-like, transcript variant X5
inter-alpha-trypsin inhibitor heavy chain H3-like isoform X4
inter-alpha-trypsin inhibitor heavy chain H3-like isoform X5
signal peptidase complex subunit 1, transcript variant X1
signal peptidase complex subunit 1, transcript variant X2
signal peptidase complex subunit 1 isoform X1
signal peptidase complex subunit 1 isoform X2
glycosyltransferase 8 domain containing 1
glycosyltransferase 8 domain-containing protein 1
guanine nucleotide binding protein-like 3 (nucleolar), transcript variant X1
guanine nucleotide-binding protein-like 3 isoform X1
guanine nucleotide binding protein-like 3 (nucleolar), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
guanine nucleotide-binding protein-like 3 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00569
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
5'-nucleotidase domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
troponin C, slow skeletal and cardiac muscles
ATR interacting protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
ATR interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC492503 homolog
inositol 1,3,4,5,6-pentakisphosphate 2-kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
extracellular matrix protein 2, female organ and adipocyte specific, transcript variant X2
extracellular matrix protein 2, female organ and adipocyte specific, transcript variant X4
extracellular matrix protein 2, female organ and adipocyte specific, transcript variant X1
extracellular matrix protein 2, female organ and adipocyte specific, transcript variant X3
extracellular matrix protein 2 isoform X1
extracellular matrix protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
nucleolar protein 8, transcript variant X1
nucleolar protein 8, transcript variant X2
ATPase plasma membrane Ca2+ transporting 2, transcript variant X9
ATPase plasma membrane Ca2+ transporting 2, transcript variant X6
ATPase plasma membrane Ca2+ transporting 2, transcript variant X3
ATPase plasma membrane Ca2+ transporting 2, transcript variant X5
ATPase plasma membrane Ca2+ transporting 2, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase plasma membrane Ca2+ transporting 2, transcript variant X20
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ATPase plasma membrane Ca2+ transporting 2, transcript variant X22
ATPase plasma membrane Ca2+ transporting 2, transcript variant X18
ATPase plasma membrane Ca2+ transporting 2, transcript variant X4
ATPase plasma membrane Ca2+ transporting 2, transcript variant X2
ATPase plasma membrane Ca2+ transporting 2, transcript variant X8
ATPase plasma membrane Ca2+ transporting 2, transcript variant X7
ATPase plasma membrane Ca2+ transporting 2, transcript variant X1
ATPase plasma membrane Ca2+ transporting 2, transcript variant X11
ATPase plasma membrane Ca2+ transporting 2, transcript variant X12
ATPase plasma membrane Ca2+ transporting 2, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ATPase plasma membrane Ca2+ transporting 2, transcript variant X25
ATPase plasma membrane Ca2+ transporting 2, transcript variant X13
ATPase plasma membrane Ca2+ transporting 2, transcript variant X15
ATPase plasma membrane Ca2+ transporting 2, transcript variant X14
ATPase plasma membrane Ca2+ transporting 2, transcript variant X16
ATPase plasma membrane Ca2+ transporting 2, transcript variant X19
ATPase plasma membrane Ca2+ transporting 2, transcript variant X21
ATPase plasma membrane Ca2+ transporting 2, transcript variant X23
ATPase plasma membrane Ca2+ transporting 2, transcript variant X10
plasma membrane calcium-transporting ATPase 2 isoform X1
plasma membrane calcium-transporting ATPase 2 isoform X4
plasma membrane calcium-transporting ATPase 2 isoform X2
plasma membrane calcium-transporting ATPase 2 isoform X5
plasma membrane calcium-transporting ATPase 2 isoform X3
plasma membrane calcium-transporting ATPase 2 isoform X6
plasma membrane calcium-transporting ATPase 2 isoform X7
plasma membrane calcium-transporting ATPase 2 isoform X12
plasma membrane calcium-transporting ATPase 2 isoform X10
plasma membrane calcium-transporting ATPase 2 isoform X14
plasma membrane calcium-transporting ATPase 2 isoform X8
plasma membrane calcium-transporting ATPase 2 isoform X11
plasma membrane calcium-transporting ATPase 2 isoform X15
plasma membrane calcium-transporting ATPase 2 isoform X16
plasma membrane calcium-transporting ATPase 2 isoform X13
plasma membrane calcium-transporting ATPase 2 isoform X9
POC1 centriolar protein homolog A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
POC1 centriolar protein homolog A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
POC1 centriolar protein homolog A-like isoform X2
POC1 centriolar protein homolog A-like isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00056
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC125460150, transcript variant X2
uncharacterized LOC125460150, transcript variant X1
shisa family member 10, tandem duplicate 1, transcript variant X1
shisa family member 10, tandem duplicate 1, transcript variant X2
5-aminolevulinate synthase, nonspecific, mitochondrial
sodium- and chloride-dependent GABA transporter 3
solute carrier family 6 member 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 6 member 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 6 member 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 120 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium- and chloride-dependent GABA transporter 1b isoform X1
sodium- and chloride-dependent GABA transporter 1b isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: histamine H1 receptor
ATG7 autophagy related 7 homolog (S. cerevisiae), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ATG7 autophagy related 7 homolog (S. cerevisiae), transcript variant X1
ubiquitin-like modifier-activating enzyme ATG7 isoform X1
ATG7 autophagy related 7 homolog (S. cerevisiae), transcript variant X3
ubiquitin-like modifier-activating enzyme ATG7 isoform X2
vestigial-like family member 4b, transcript variant X3
vestigial-like family member 4b, transcript variant X2
vestigial-like family member 4b, transcript variant X1
vestigial-like family member 4b, transcript variant X4
transcription cofactor vestigial-like protein 4b isoform X3
transcription cofactor vestigial-like protein 4b isoform X2
transcription cofactor vestigial-like protein 4b isoform X1
transcription cofactor vestigial-like protein 4b isoform X4
TAM41 mitochondrial translocator assembly and maintenance homolog, transcript variant X1
TAM41 mitochondrial translocator assembly and maintenance homolog, transcript variant X2
phosphatidate cytidylyltransferase, mitochondrial isoform X1
phosphatidate cytidylyltransferase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
metalloproteinase inhibitor 3-like, transcript variant X2
metalloproteinase inhibitor 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
metalloproteinase inhibitor 3-like isoform X1
metalloproteinase inhibitor 3-like isoform X2
peroxisome proliferator-activated receptor gamma, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 222 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 222 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 222 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 222 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma, transcript variant X5
peroxisome proliferator-activated receptor gamma, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 222 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
peroxisome proliferator-activated receptor gamma, transcript variant X6
peroxisome proliferator-activated receptor gamma
TSEN2 tRNA splicing endonuclease subunit, transcript variant X1
TSEN2 tRNA splicing endonuclease subunit, transcript variant X2
TSEN2 tRNA splicing endonuclease subunit, transcript variant X3
tRNA-splicing endonuclease subunit Sen2 isoform X1
TSEN2 tRNA splicing endonuclease subunit, transcript variant X4
tRNA-splicing endonuclease subunit Sen2 isoform X2
MKRN2 opposite strand protein-like, transcript variant X2
MKRN2 opposite strand protein-like, transcript variant X1
makorin, ring finger protein, 2, transcript variant X2
makorin, ring finger protein, 2, transcript variant X1
E3 ubiquitin-protein ligase makorin-2 isoform X1
E3 ubiquitin-protein ligase makorin-2 isoform X2
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X2
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X1
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X6
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X3
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X7
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X4
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X5
RAF proto-oncogene serine/threonine-protein kinase-like, transcript variant X8
RAF proto-oncogene serine/threonine-protein kinase-like isoform X2
RAF proto-oncogene serine/threonine-protein kinase-like isoform X1
RAF proto-oncogene serine/threonine-protein kinase-like isoform X3
CCHC-type zinc finger, nucleic acid binding protein b, transcript variant X2
CCHC-type zinc finger, nucleic acid binding protein b, transcript variant X6
CCHC-type zinc finger, nucleic acid binding protein b, transcript variant X1
CCHC-type zinc finger, nucleic acid binding protein b, transcript variant X5
CCHC-type zinc finger, nucleic acid binding protein b, transcript variant X3
CCHC-type zinc finger, nucleic acid binding protein b, transcript variant X4
CCHC-type zinc finger, nucleic acid binding protein b isoform X3
CCHC-type zinc finger, nucleic acid binding protein b isoform X1
CCHC-type zinc finger, nucleic acid binding protein b isoform X2
uncharacterized protein LOC402927 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
haloacid dehalogenase-like hydrolase domain-containing 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 113 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
glycoprotein IX (platelet), transcript variant X3
glycoprotein IX (platelet), transcript variant X2
glycoprotein IX (platelet), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glycoprotein IX (platelet), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cilia and flagella associated protein 92 (putative), transcript variant X1
uncharacterized protein cfap92 isoform X1
EF-hand and coiled-coil domain containing 1
EF-hand and coiled-coil domain-containing protein 1
cilia and flagella associated protein 92 (putative), transcript variant X2
uncharacterized protein cfap92 isoform X2
acyl-CoA dehydrogenase family, member 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
acyl-CoA dehydrogenase family, member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
complex I assembly factor ACAD9, mitochondrial isoform X1
complex I assembly factor ACAD9, mitochondrial isoform X2
acyl-CoA dehydrogenase family, member 9, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
complex I assembly factor ACAD9, mitochondrial isoform X3
IQ motif and Sec7 domain ArfGEF 1b, transcript variant X2
IQ motif and Sec7 domain ArfGEF 1b, transcript variant X1
IQ motif and Sec7 domain ArfGEF 1b, transcript variant X5
IQ motif and Sec7 domain ArfGEF 1b, transcript variant X3
IQ motif and Sec7 domain ArfGEF 1b, transcript variant X4
IQ motif and SEC7 domain-containing protein 1 isoform X2
IQ motif and SEC7 domain-containing protein 1 isoform X1
IQ motif and SEC7 domain-containing protein 1 isoform X5
IQ motif and SEC7 domain-containing protein 1 isoform X3
IQ motif and SEC7 domain-containing protein 1 isoform X4
IQ motif and Sec7 domain ArfGEF 1b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
IQ motif and SEC7 domain-containing protein 1 isoform X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
histone deacetylase 11, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
histone deacetylase 11, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
F-box and WD repeat domain containing 12, transcript variant X3
F-box and WD repeat domain containing 12, transcript variant X1
F-box and WD repeat domain containing 12, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
F-box and WD repeat domain containing 12, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
F-box/WD repeat-containing protein 12 isoform X2
F-box/WD repeat-containing protein 12 isoform X1
F-box/WD repeat-containing protein 12 isoform X3
uncharacterized LOC125460260, transcript variant X2
uncharacterized LOC125460260, transcript variant X1
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X5
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tyrosine phosphatase domain-containing protein 1-like isoform X4
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X8
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X4
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X2
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X7
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X3
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X1
protein tyrosine phosphatase domain-containing protein 1-like isoform X2
protein tyrosine phosphatase domain-containing protein 1-like isoform X3
protein tyrosine phosphatase domain-containing protein 1-like isoform X5
protein tyrosine phosphatase domain-containing protein 1-like isoform X1
uncharacterized LOC125460426, transcript variant X1
uncharacterized LOC125460426, transcript variant X2
uncharacterized LOC125460426, transcript variant X3
constitutive coactivator of PPAR-gamma-like protein 1, transcript variant X2
constitutive coactivator of PPAR-gamma-like protein 1, transcript variant X1
constitutive coactivator of PPAR-gamma-like protein 1 isoform X2
constitutive coactivator of PPAR-gamma-like protein 1 homolog isoform X1
WNK lysine deficient protein kinase 2, transcript variant X3
WNK lysine deficient protein kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
WNK lysine deficient protein kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
WNK lysine deficient protein kinase 2, transcript variant X1
serine/threonine-protein kinase WNK2 isoform X3
serine/threonine-protein kinase WNK2 isoform X4
serine/threonine-protein kinase WNK3 isoform X2
serine/threonine-protein kinase WNK2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
caspase recruitment domain family, member 19, transcript variant X2
caspase recruitment domain family, member 19, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
caspase recruitment domain family, member 19, transcript variant X3
caspase recruitment domain family, member 19, transcript variant X6
caspase recruitment domain family, member 19, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
caspase recruitment domain family, member 19, transcript variant X7
caspase recruitment domain family, member 19, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
caspase recruitment domain family, member 19 isoform X2
caspase recruitment domain family, member 19 isoform X1
caspase recruitment domain family, member 19 isoform X3
caspase recruitment domain family, member 19 isoform X4
uncharacterized LOC125460599, transcript variant X2
uncharacterized LOC125460599, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins
protein bicaudal D homolog 2-like, transcript variant X2
protein bicaudal D homolog 2-like, transcript variant X1
protein bicaudal D homolog 2-like isoform X2
protein bicaudal D homolog 2-like isoform X1
transketolase-like, transcript variant X1
transketolase-like, transcript variant X2
decapping mRNA 1A, transcript variant X1
decapping mRNA 1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit alpha-1D-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
choline dehydrogenase, transcript variant X1
choline dehydrogenase, transcript variant X2
interleukin-17 receptor B, transcript variant X1
interleukin-17 receptor B, transcript variant X2
actin related protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
actin related protein 8, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins
calcium channel, voltage-dependent, alpha 2/delta subunit 3a, transcript variant X1
calcium channel, voltage-dependent, alpha 2/delta subunit 3a, transcript variant X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
calcium channel, voltage-dependent, alpha 2/delta subunit 3a, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X3
calcium channel, voltage-dependent, alpha 2/delta subunit 3a, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X4
calcium channel, voltage-dependent, alpha 2/delta subunit 3a, transcript variant X5
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X5
leucine-rich repeat and transmembrane domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
wingless-type MMTV integration site family, member 5a, transcript variant X2
wingless-type MMTV integration site family, member 5a, transcript variant X10
wingless-type MMTV integration site family, member 5a, transcript variant X4
wingless-type MMTV integration site family, member 5a, transcript variant X6
wingless-type MMTV integration site family, member 5a, transcript variant X3
wingless-type MMTV integration site family, member 5a, transcript variant X5
wingless-type MMTV integration site family, member 5a, transcript variant X1
wingless-type MMTV integration site family, member 5a, transcript variant X7
wingless-type MMTV integration site family, member 5a, transcript variant X8
wingless-type MMTV integration site family, member 5a, transcript variant X9
ELKS/Rab6-interacting/CAST family member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Rho guanine nucleotide exchange factor (GEF) 3, transcript variant X1
rho guanine nucleotide exchange factor 3 isoform X1
Rho guanine nucleotide exchange factor (GEF) 3, transcript variant X2
rho guanine nucleotide exchange factor 3 isoform X2
Rho guanine nucleotide exchange factor (GEF) 3, transcript variant X4
rho guanine nucleotide exchange factor 3 isoform X4
Rho guanine nucleotide exchange factor (GEF) 3, transcript variant X3
rho guanine nucleotide exchange factor 3 isoform X3
Rho guanine nucleotide exchange factor (GEF) 3, transcript variant X5
rho guanine nucleotide exchange factor 3 isoform X5
protein TASOR-like, transcript variant X1
protein TASOR-like, transcript variant X3
protein TASOR-like, transcript variant X2
protein TASOR-like, transcript variant X4
protein TASOR-like, transcript variant X5
coiled-coil domain containing 66, transcript variant X6
coiled-coil domain containing 66, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
coiled-coil domain containing 66, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
coiled-coil domain containing 66, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
coiled-coil domain containing 66, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
coiled-coil domain containing 66, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
coiled-coil domain containing 66, transcript variant X8
coiled-coil domain containing 66, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain-containing protein 66 isoform X4
coiled-coil domain-containing protein 66 isoform X6
coiled-coil domain-containing protein 66 isoform X2
coiled-coil domain-containing protein 66 isoform X3
coiled-coil domain-containing protein 66 isoform X1
coiled-coil domain-containing protein 66 isoform X5
leucine rich repeat neuronal 1, transcript variant X1
leucine rich repeat neuronal 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tRNA nucleotidyl transferase, CCA-adding, 1
CCA tRNA nucleotidyltransferase 1, mitochondrial
neural cell adhesion molecule L1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
contactin-4-like, transcript variant X17
contactin-4-like, transcript variant X11
contactin-4-like, transcript variant X15
contactin-4-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
contactin-4-like, transcript variant X16
contactin-4-like, transcript variant X10
contactin-4-like, transcript variant X13
contactin-4-like, transcript variant X12
contactin-4-like, transcript variant X18
PDZ domain containing RING finger 3b, transcript variant X4
PDZ domain containing RING finger 3b, transcript variant X2
PDZ domain containing RING finger 3b, transcript variant X3
PDZ domain containing RING finger 3b, transcript variant X1
E3 ubiquitin-protein ligase PDZRN3-B isoform X1
E3 ubiquitin-protein ligase PDZRN3-B isoform X2
PDZ domain containing RING finger 3b, transcript variant X5
E3 ubiquitin-protein ligase PDZRN3-B isoform X3
protein phosphatase 4, regulatory subunit 2b, transcript variant X3
protein phosphatase 4, regulatory subunit 2b, transcript variant X2
protein phosphatase 4, regulatory subunit 2b, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 2-B isoform X3
serine/threonine-protein phosphatase 4 regulatory subunit 2-B isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 2-B isoform X1
SHQ1, H/ACA ribonucleoprotein assembly factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
SHQ1, H/ACA ribonucleoprotein assembly factor, transcript variant X2
RING1 and YY1 binding protein b, transcript variant X2
RING1 and YY1 binding protein b, transcript variant X1
RING1 and YY1-binding protein B isoform X1
RING1 and YY1-binding protein B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein-coupled receptor 27, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
G protein-coupled receptor 27, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
G protein-coupled receptor 27, transcript variant X3
eukaryotic translation initiation factor 4E family member 3
eukaryotic translation initiation factor 4E type 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins
myoD family inhibitor domain-containing protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
myoD family inhibitor domain-containing protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
myoD family inhibitor domain-containing protein-like
microphthalmia-associated transcription factor-like, transcript variant X1
microphthalmia-associated transcription factor-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microphthalmia-associated transcription factor-like, transcript variant X6
microphthalmia-associated transcription factor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
microphthalmia-associated transcription factor-like, transcript variant X7
microphthalmia-associated transcription factor-like, transcript variant X5
microphthalmia-associated transcription factor-like, transcript variant X3
microphthalmia-associated transcription factor-like, transcript variant X8
microphthalmia-associated transcription factor-like isoform X1
microphthalmia-associated transcription factor-like isoform X2
microphthalmia-associated transcription factor-like isoform X5
microphthalmia-associated transcription factor-like isoform X3
microphthalmia-associated transcription factor-like isoform X4
microphthalmia-associated transcription factor-like isoform X6
FERM domain-containing protein 4B-like, transcript variant X3
FERM domain-containing protein 4B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FERM domain-containing protein 4B-like, transcript variant X2
FERM domain-containing protein 4B-like isoform X2
FERM domain-containing protein 4B-like isoform X1
FERM domain-containing protein 4B-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
PRA1 family protein 3-like, transcript variant X1
PRA1 family protein 3-like, transcript variant X2
ubiquitin-like modifier activating enzyme 3, transcript variant X1
ubiquitin-like modifier activating enzyme 3, transcript variant X2
ubiquitin-like modifier activating enzyme 3, transcript variant X3
NEDD8-activating enzyme E1 catalytic subunit isoform X1
NEDD8-activating enzyme E1 catalytic subunit isoform X2
ubiquitin-like modifier activating enzyme 3, transcript variant X4
NEDD8-activating enzyme E1 catalytic subunit isoform X3
NEDD8-activating enzyme E1 catalytic subunit isoform X4
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
TATA element modulatory factor 1, transcript variant X1
TATA element modulatory factor 1, transcript variant X2
TATA element modulatory factor isoform X1
TATA element modulatory factor isoform X2
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X7
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X4
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X5
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X2
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X1
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X6
EGF domain-specific O-linked N-acetylglucosamine (GlcNAc) transferase, transcript variant X3
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X1
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X2
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X4
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X3
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X5
TAFA chemokine like family member 4b, transcript variant X1
TAFA chemokine like family member 4b, transcript variant X2
chemokine-like protein TAFA-4b isoform X1
TAFA chemokine like family member 4b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chemokine-like protein TAFA-4b isoform X2
chemokine-like protein TAFA-1, transcript variant X2
chemokine-like protein TAFA-1, transcript variant X1
chemokine-like protein TAFA-1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
chemokine-like protein TAFA-1 isoform X2
chemokine-like protein TAFA-1 isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
succinate-CoA ligase GDP-forming subunit beta, transcript variant X10
succinate-CoA ligase GDP-forming subunit beta, transcript variant X2
succinate-CoA ligase GDP-forming subunit beta, transcript variant X1
succinate-CoA ligase GDP-forming subunit beta, transcript variant X6
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X2
succinate-CoA ligase GDP-forming subunit beta, transcript variant X7
succinate-CoA ligase GDP-forming subunit beta, transcript variant X9
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X1
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X8
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X6
succinate-CoA ligase GDP-forming subunit beta, transcript variant X3
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X3
succinate-CoA ligase GDP-forming subunit beta, transcript variant X4
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X4
succinate-CoA ligase GDP-forming subunit beta, transcript variant X5
succinate-CoA ligase GDP-forming subunit beta, transcript variant X8
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X5
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X7
succinate-CoA ligase GDP-forming subunit beta, transcript variant X11
succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial isoform X9
kelch repeat and BTB (POZ) domain containing 8, transcript variant X1
kelch repeat and BTB (POZ) domain containing 8, transcript variant X2
kelch repeat and BTB domain-containing protein 8 isoform X1
kelch repeat and BTB domain-containing protein 8 isoform X2
leucine-rich repeats and immunoglobulin-like domains 1, transcript variant X3
leucine-rich repeats and immunoglobulin-like domains 1, transcript variant X1
leucine-rich repeats and immunoglobulin-like domains 1, transcript variant X2
leucine-rich repeats and immunoglobulin-like domains protein 1 isoform X1
leucine-rich repeats and immunoglobulin-like domains protein 1 isoform X2
solute carrier family 25 member 26, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
S-adenosylmethionine mitochondrial carrier protein isoform X3
solute carrier family 25 member 26, transcript variant X4
S-adenosylmethionine mitochondrial carrier protein isoform X4
solute carrier family 25 member 26, transcript variant X1
solute carrier family 25 member 26, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
S-adenosylmethionine mitochondrial carrier protein isoform X2
S-adenosylmethionine mitochondrial carrier protein isoform X1
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X6
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X6
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X7
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X4
membrane associated guanylate kinase, WW and PDZ domain containing 1b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1b isoform X5
uncharacterized LOC125460167, transcript variant X2
uncharacterized LOC125460167, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif, 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ADAM metallopeptidase with thrombospondin type 1 motif, 9, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif, 9, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif, 9, transcript variant X4
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X3
prickle homolog 2b, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
prickle homolog 2b, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
prickle homolog 2b, transcript variant X8
prickle homolog 2b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
prickle homolog 2b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
prickle homolog 2b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
prickle homolog 2b, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
prickle homolog 2b, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
prickle homolog 2b, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
prickle homolog 2b, transcript variant X10
proteasome 26S subunit, non-ATPase 6, transcript variant X1
proteasome 26S subunit, non-ATPase 6, transcript variant X2
26S proteasome non-ATPase regulatory subunit 6 isoform X1
26S proteasome non-ATPase regulatory subunit 6 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
THO complex subunit 7 homolog isoform X1
THO complex subunit 7 homolog isoform X2
putative uncharacterized protein C3orf49
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Ca2+-dependent activator protein for secretion a, transcript variant X13
Ca2+-dependent activator protein for secretion a, transcript variant X1
Ca2+-dependent activator protein for secretion a, transcript variant X2
Ca2+-dependent activator protein for secretion a, transcript variant X3
Ca2+-dependent activator protein for secretion a, transcript variant X7
Ca2+-dependent activator protein for secretion a, transcript variant X10
Ca2+-dependent activator protein for secretion a, transcript variant X11
Ca2+-dependent activator protein for secretion a, transcript variant X4
Ca2+-dependent activator protein for secretion a, transcript variant X9
Ca2+-dependent activator protein for secretion a, transcript variant X12
Ca2+-dependent activator protein for secretion a, transcript variant X5
Ca2+-dependent activator protein for secretion a, transcript variant X6
Ca2+-dependent activator protein for secretion a, transcript variant X8
calcium-dependent secretion activator 1 isoform X13
calcium-dependent secretion activator 1 isoform X2
calcium-dependent secretion activator 1 isoform X3
calcium-dependent secretion activator 1 isoform X1
calcium-dependent secretion activator 1 isoform X5
calcium-dependent secretion activator 1 isoform X7
calcium-dependent secretion activator 1 isoform X10
calcium-dependent secretion activator 1 isoform X11
calcium-dependent secretion activator 1 isoform X4
calcium-dependent secretion activator 1 isoform X9
calcium-dependent secretion activator 1 isoform X6
calcium-dependent secretion activator 1 isoform X8
calcium-dependent secretion activator 1 isoform X12
uncharacterized LOC125460481, transcript variant X1
FEZ family zinc finger 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FEZ family zinc finger 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
fez family zinc finger protein 2 isoform X1
fez family zinc finger protein 2 isoform X2
uncharacterized LOC125460481, transcript variant X2
chromosome 17 C3orf14 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
chromosome 17 C3orf14 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
chromosome 17 C3orf14 homolog, transcript variant X5
chromosome 17 C3orf14 homolog, transcript variant X6
chromosome 17 C3orf14 homolog, transcript variant X1
chromosome 17 C3orf14 homolog, transcript variant X4
chromosome 17 C3orf14 homolog, transcript variant X7
receptor-type tyrosine-protein phosphatase gamma-like, transcript variant X1
receptor-type tyrosine-protein phosphatase gamma-like, transcript variant X2
receptor-type tyrosine-protein phosphatase gamma-like isoform X1
receptor-type tyrosine-protein phosphatase gamma-like isoform X2
fragile histidine triad diadenosine triphosphatase, transcript variant X3
fragile histidine triad diadenosine triphosphatase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
fragile histidine triad diadenosine triphosphatase, transcript variant X6
fragile histidine triad diadenosine triphosphatase, transcript variant X5
fragile histidine triad diadenosine triphosphatase, transcript variant X1
fragile histidine triad diadenosine triphosphatase, transcript variant X7
bis(5'-adenosyl)-triphosphatase isoform X1
bis(5'-adenosyl)-triphosphatase isoform X3
fragile histidine triad diadenosine triphosphatase, transcript variant X4
bis(5'-adenosyl)-triphosphatase isoform X2
CFAP20 domain containing, transcript variant X1
CFAP20 domain containing, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CFAP20 domain containing, transcript variant X3
uncharacterized protein C3orf67 homolog isoform X1
uncharacterized protein C3orf67 homolog isoform X2
uncharacterized protein C3orf67 homolog isoform X3
protein FAM3A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein FAM3A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein FAM107B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein FAM107B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein FAM107B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein FAM107B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein FAM107B-like, transcript variant X4
protein FAM107B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
peroxisomal acyl-coenzyme A oxidase 2-like, transcript variant X1
peroxisomal acyl-coenzyme A oxidase 2-like, transcript variant X2
peroxisomal acyl-coenzyme A oxidase 2-like isoform X1
peroxisomal acyl-coenzyme A oxidase 2-like isoform X2
potassium channel tetramerization domain containing 6a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
potassium channel tetramerization domain containing 6a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
BTB/POZ domain-containing protein KCTD6a isoform X1
BTB/POZ domain-containing protein KCTD6a isoform X2
pyruvate dehydrogenase E1 component subunit beta, mitochondrial
PX domain containing serine/threonine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
PX domain-containing protein kinase-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC125460381, transcript variant X2
uncharacterized LOC125460381, transcript variant X1
uncharacterized LOC125460381, transcript variant X3
sarcolemma associated protein a, transcript variant X5
sarcolemma associated protein a, transcript variant X2
sarcolemma associated protein a, transcript variant X7
sarcolemma associated protein a, transcript variant X4
sarcolemma associated protein a, transcript variant X9
sarcolemma associated protein a, transcript variant X8
sarcolemma associated protein a, transcript variant X6
sarcolemma associated protein a, transcript variant X1
sarcolemma associated protein a, transcript variant X3
sarcolemma associated protein a, transcript variant X18
sarcolemma associated protein a, transcript variant X17
sarcolemma associated protein a, transcript variant X12
sarcolemma associated protein a, transcript variant X15
sarcolemma associated protein a, transcript variant X10
sarcolemma associated protein a, transcript variant X19
sarcolemma associated protein a, transcript variant X16
sarcolemma associated protein a, transcript variant X13
sarcolemma associated protein a, transcript variant X11
sarcolemma associated protein a, transcript variant X14
sarcolemma associated protein a, transcript variant X20
sarcolemma associated protein a, transcript variant X24
sarcolemma associated protein a, transcript variant X23
sarcolemma associated protein a, transcript variant X22
sarcolemma associated protein a, transcript variant X21
sarcolemma associated protein a isoform X20
sarcolemma associated protein a isoform X18
sarcolemma associated protein a isoform X17
sarcolemma associated protein a isoform X12
sarcolemma associated protein a isoform X5
sarcolemma associated protein a isoform X15
sarcolemma associated protein a isoform X10
sarcolemma associated protein a isoform X2
sarcolemma associated protein a isoform X19
sarcolemma associated protein a isoform X16
sarcolemma associated protein a isoform X13
sarcolemma associated protein a isoform X7
sarcolemma associated protein a isoform X11
sarcolemma associated protein a isoform X4
sarcolemma associated protein a isoform X14
sarcolemma associated protein a isoform X9
sarcolemma associated protein a isoform X8
sarcolemma associated protein a isoform X6
sarcolemma associated protein a isoform X1
sarcolemma associated protein a isoform X21
sarcolemma associated protein a isoform X24
sarcolemma associated protein a isoform X23
sarcolemma associated protein a isoform X22
sarcolemma associated protein a isoform X3
ATPase H+ transporting accessory protein 1 like a
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X7
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X6
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X4
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X5
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X3
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X2
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X1
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X8
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1, transcript variant X9
DCC-interacting protein 13-alpha isoform X3
DCC-interacting protein 13-alpha isoform X2
DCC-interacting protein 13-alpha isoform X1
DCC-interacting protein 13-alpha isoform X4
DCC-interacting protein 13-alpha isoform X5
dual specificity tyrosine-phosphorylation-regulated kinase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
bassoon (presynaptic cytomatrix protein) b, transcript variant X4
bassoon (presynaptic cytomatrix protein) b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
bassoon (presynaptic cytomatrix protein) b, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
bassoon (presynaptic cytomatrix protein) b, transcript variant X5
bassoon (presynaptic cytomatrix protein) b, transcript variant X3
bassoon (presynaptic cytomatrix protein) b, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bassoon (presynaptic cytomatrix protein) b, transcript variant X8
bassoon (presynaptic cytomatrix protein) b, transcript variant X6
bassoon (presynaptic cytomatrix protein) b, transcript variant X9
uncharacterized LOC125460242, transcript variant X1
uncharacterized LOC125460242, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
F-actin-capping protein subunit alpha-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
LIM and cysteine-rich domains 1, transcript variant X1
LIM and cysteine-rich domains 1, transcript variant X2
LIM and cysteine-rich domains protein 1 isoform X1
LIM and cysteine-rich domains protein 1 isoform X2
metabotropic glutamate receptor 7-like, transcript variant X2
metabotropic glutamate receptor 7-like isoform X2
metabotropic glutamate receptor 7-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
metabotropic glutamate receptor 7-like isoform X1
ER degradation enhancer, mannosidase alpha-like 1, transcript variant X2
ER degradation enhancer, mannosidase alpha-like 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ER degradation-enhancing alpha-mannosidase-like protein 1 isoform X2
ER degradation-enhancing alpha-mannosidase-like protein 1 isoform X1
ADP-ribosylation factor-like protein 8B-A
basic helix-loop-helix family, member e40, transcript variant X2
basic helix-loop-helix family, member e40, transcript variant X1
class E basic helix-loop-helix protein 40 isoform X1
class E basic helix-loop-helix protein 40 isoform X2
inositol 1,4,5-trisphosphate receptor, type 1b, transcript variant X2
inositol 1,4,5-trisphosphate receptor, type 1b, transcript variant X5
inositol 1,4,5-trisphosphate receptor, type 1b, transcript variant X4
inositol 1,4,5-trisphosphate receptor, type 1b, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor, type 1b, transcript variant X3
inositol 1,4,5-trisphosphate receptor, type 1b, transcript variant X6
inositol 1,4,5-trisphosphate receptor type 1 isoform X3
inositol 1,4,5-trisphosphate receptor type 1 isoform X2
inositol 1,4,5-trisphosphate receptor type 1 isoform X1
inositol 1,4,5-trisphosphate receptor type 1 isoform X4
formylglycine-generating enzyme-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
formylglycine-generating enzyme-like, transcript variant X1
formylglycine-generating enzyme-like isoform X2
formylglycine-generating enzyme-like isoform X1
SET domain and mariner transposase fusion gene
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
histone-lysine N-methyltransferase SETMAR
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3H, transcript variant X2
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3H, transcript variant X1
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3H isoform X2
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3H isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger MYND domain-containing protein 10
Ras association domain family member 1, transcript variant X2
Ras association domain family member 1, transcript variant X1
ras association domain-containing protein 1 isoform X1
ras association domain-containing protein 1 isoform X2
Ras association domain family member 1, transcript variant X3
ras association domain-containing protein 1 isoform X3
RAD18 E3 ubiquitin protein ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RAD18 E3 ubiquitin protein ligase, transcript variant X2
E3 ubiquitin-protein ligase RAD18 isoform X1
E3 ubiquitin-protein ligase RAD18 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
interleukin-1 receptor-associated kinase-like 2, transcript variant X1
interleukin-1 receptor-associated kinase-like 2, transcript variant X2
interleukin-1 receptor-associated kinase-like 2, transcript variant X3
interleukin-1 receptor-associated kinase-like 2 isoform X1
interleukin-1 receptor-associated kinase-like 2 isoform X2
interleukin-1 receptor-associated kinase-like 2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain-containing protein 174
cullin-associated NEDD8-dissociated protein 1-like, transcript variant X1
cullin-associated NEDD8-dissociated protein 1-like, transcript variant X2
cullin-associated NEDD8-dissociated protein 1-like isoform X1
cullin-associated NEDD8-dissociated protein 1-like isoform X2
SEC13 homolog, nuclear pore and COPII coat complex component
glutamate receptor interacting protein 2b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
glutamate receptor-interacting protein 2
thyrotropin-releasing hormone, transcript variant X2
thyrotropin-releasing hormone, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X6
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
SLIT-ROBO Rho GTPase-activating protein 3 isoform X1
SLIT-ROBO Rho GTPase-activating protein 3 isoform X2
SLIT-ROBO Rho GTPase-activating protein 3 isoform X4
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X5
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X3
SLIT-ROBO Rho GTPase-activating protein 3 isoform X3
SLIT-ROBO Rho GTPase-activating protein 3 isoform X5
uncharacterized LOC125460249, transcript variant X2
uncharacterized LOC125460249, transcript variant X1
von Hippel-Lindau disease tumor suppressor
BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase BAP1
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
aminomethyltransferase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
aminomethyltransferase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
aminomethyltransferase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
aminomethyltransferase, mitochondrial isoform X3
aminomethyltransferase, mitochondrial isoform X1
aminomethyltransferase, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
MAP kinase-activated protein kinase 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
DDB1- and CUL4-associated factor 1-like, transcript variant X2
DDB1- and CUL4-associated factor 1-like, transcript variant X3
DDB1- and CUL4-associated factor 1-like, transcript variant X1
DDB1- and CUL4-associated factor 1-like isoform X1
DDB1- and CUL4-associated factor 1-like isoform X2
uncharacterized LOC125460171, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125460171, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
poly(rC) binding protein 4, transcript variant X4
poly(rC) binding protein 4, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
poly(rC) binding protein 4, transcript variant X7
poly(rC) binding protein 4, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
poly(rC) binding protein 4, transcript variant X5
poly(rC) binding protein 4, transcript variant X1
poly(rC) binding protein 4, transcript variant X3
poly(rC) binding protein 4, transcript variant X2
NPR2 like, GATOR1 complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
NPR2 like, GATOR1 complex subunit, transcript variant X2
protein SSUH2 homolog, transcript variant X4
protein SSUH2 homolog, transcript variant X1
protein SSUH2 homolog, transcript variant X3
protein SSUH2 homolog, transcript variant X2
mesencephalic astrocyte-derived neurotrophic factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
inositol hexakisphosphate kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
inositol hexakisphosphate kinase 1 isoform X1
inositol hexakisphosphate kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
inositol hexakisphosphate kinase 1 isoform X2
E3 ubiquitin-protein ligase RNF123, transcript variant X1
E3 ubiquitin-protein ligase RNF123, transcript variant X2
E3 ubiquitin-protein ligase RNF123 isoform X1
E3 ubiquitin-protein ligase RNF123 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
GDP-mannose pyrophosphorylase B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
GDP-mannose pyrophosphorylase B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
mannose-1-phosphate guanyltransferase beta
abhydrolase domain containing 14B, transcript variant X1
abhydrolase domain containing 14B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
telomeric repeat binding factor 2, interacting protein
telomeric repeat-binding factor 2-interacting protein 1
E3 SUMO-protein ligase ZBED1-like, transcript variant X4
E3 SUMO-protein ligase ZBED1-like, transcript variant X1
E3 SUMO-protein ligase ZBED1-like, transcript variant X2
E3 SUMO-protein ligase ZBED1-like, transcript variant X3
E3 SUMO-protein ligase ZBED1-like, transcript variant X5
E3 SUMO-protein ligase ZBED1-like, transcript variant X6
glutamate receptor, metabotropic 2a, transcript variant X2
glutamate receptor, metabotropic 2a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 40 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glutamate receptor, metabotropic 2a isoform X2
glutamate receptor, metabotropic 2a isoform X1
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein, transcript variant X1
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein, transcript variant X2
U3 small nucleolar RNA-interacting protein 2 isoform X1
U3 small nucleolar RNA-interacting protein 2 isoform X2
poly (ADP-ribose) polymerase family, member 3
protein mono-ADP-ribosyltransferase PARP3
cadherin-related family member 4-like, transcript variant X5
cadherin-related family member 4-like, transcript variant X6
cadherin-related family member 4-like, transcript variant X2
cadherin-related family member 4-like, transcript variant X1
cadherin-related family member 4-like, transcript variant X4
cadherin-related family member 4-like, transcript variant X3
cadherin-related family member 4-like isoform X5
cadherin-related family member 4-like isoform X6
cadherin-related family member 4-like isoform X2
cadherin-related family member 4-like isoform X1
cadherin-related family member 4-like isoform X4
cadherin-related family member 4-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium channel, voltage-dependent, alpha 2/delta subunit 2a, transcript variant X1
calcium channel, voltage-dependent, alpha 2/delta subunit 2a, transcript variant X2
calcium channel, voltage-dependent, alpha 2/delta subunit 2a, transcript variant X3
voltage-dependent calcium channel subunit alpha-2/delta-2a isoform X1
voltage-dependent calcium channel subunit alpha-2/delta-2a isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-2a isoform X3
calcium channel, voltage-dependent, alpha 2/delta subunit 2a, transcript variant X4
voltage-dependent calcium channel subunit alpha-2/delta-2a isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
methyl-CpG binding domain protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
methyl-CpG binding domain protein 4, transcript variant X6
methyl-CpG binding domain protein 4, transcript variant X4
methyl-CpG binding domain protein 4, transcript variant X7
methyl-CpG binding domain protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
methyl-CpG binding domain protein 4, transcript variant X5
methyl-CpG binding domain protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
methyl-CpG-binding domain protein 4 isoform X2
methyl-CpG-binding domain protein 4 isoform X1
intraflagellar transport 122 homolog (Chlamydomonas)
intraflagellar transport protein 122 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transmembrane and coiled-coil domains protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
ribosomal protein L32, transcript variant X2
ribosomal protein L32, transcript variant X1
cyclin-dependent kinase 17-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
cyclin-dependent kinase 17-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclin-dependent kinase 17-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclin-dependent kinase 17-like, transcript variant X3
cyclin-dependent kinase 17-like, transcript variant X5
cyclin-dependent kinase 16-like isoform X4
cyclin-dependent kinase 17-like isoform X1
cyclin-dependent kinase 17-like isoform X3
cyclin-dependent kinase 17-like isoform X2
cyclin-dependent kinase 16-like isoform X5
NCK-interacting protein with SH3 domain-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
NCK-interacting protein with SH3 domain-like, transcript variant X4
NCK-interacting protein with SH3 domain-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
NCK-interacting protein with SH3 domain-like, transcript variant X1
NCK-interacting protein with SH3 domain-like isoform X3
NCK-interacting protein with SH3 domain-like isoform X5
NCK-interacting protein with SH3 domain-like isoform X4
uncharacterized protein LOC125460239 isoform X1
NCK-interacting protein with SH3 domain-like, transcript variant X2
uncharacterized protein LOC125460239 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 76% coverage of the annotated genomic feature by RNAseq alignments
FYVE, RhoGEF and PH domain-containing protein 5-like
nuclear receptor subfamily 2 group C member 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments